Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current status of theranostics in prostate cancer.
Virgolini I, Decristoforo C, Haug A, Fanti S, Uprimny C. Virgolini I, et al. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):471-495. doi: 10.1007/s00259-017-3882-2. Epub 2017 Dec 28. Eur J Nucl Med Mol Imaging. 2018. PMID: 29282518 Free PMC article. Review.
111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
Li S, Kurtaran A, Li M, Traub-Weidinger T, Kienast O, Schima W, Angelberger P, Virgolini I, Raderer M, Dudczak R. Li S, et al. Among authors: virgolini i. Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1087-95. doi: 10.1007/s00259-003-1206-1. Epub 2003 May 24. Eur J Nucl Med Mol Imaging. 2003. PMID: 12768334 Clinical Trial.
Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET.
Rodrigues M, Traub-Weidinger T, Leimer M, Li S, Andreae F, Angelberger P, Dudczak R, Virgolini I. Rodrigues M, et al. Among authors: virgolini i. Eur J Nucl Med Mol Imaging. 2005 Oct;32(10):1144-51. doi: 10.1007/s00259-005-1820-1. Epub 2005 May 21. Eur J Nucl Med Mol Imaging. 2005. PMID: 15909194 Clinical Trial.
Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.
Gabriel M, Hausler F, Bale R, Moncayo R, Decristoforo C, Kovacs P, Virgolini I. Gabriel M, et al. Among authors: virgolini i. Eur J Nucl Med Mol Imaging. 2005 Dec;32(12):1440-51. doi: 10.1007/s00259-005-1875-z. Epub 2005 Aug 26. Eur J Nucl Med Mol Imaging. 2005. PMID: 16133384 Clinical Trial.
313 results